Wednesday, January 15, 2014

Monitoring Inactive Hepatitis B Patients Is Cost-Effective Strategy

Jan. 15, 2014 — A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level.


The World Health Organization (WHO) estimates that roughly 2 billion individuals worldwide have been infected with HBV -- a virus causing acute or chronic liver disease that may lead to cirrhosis or liver cancer (hepatocellular carcinoma, HCC). WHO reports that 240 million are living with chronic HBV, with 1.4 million of those individuals in the U.S. according to estimates from the Centers for Disease Control and Prevention (CDC).

Read more...

No comments:

Post a Comment